Bridging Innovation Program – Philadelphia
The 2022 edition of the Bridging Innovation Program – Gene&Cell Therapy – involved the Philadelphia hub, a leader in the advanced therapies sector. It has been a path dedicated to startups, companies and research centers in Emilia-Romagna subscribed to ClustER Health, to encourage them to get closer to the Philadelphia ecosystem and to expand relationships and mutual exchanges.